how common are glp 1 side effects Ozempic and GLP-1 Drugs: Risk of Severe Long-Term Effects Of GLP-1 Medications:

JAMA 2023;330:163140.ArticlePubMedPMC 37

Lawan A, Min K, Zhang L, Canfran-Duque A, Jurczak MJ, Camporez JPG, Nie Y, Gavin TP, Shulman GI, Fernandez-Hernando C, Bennett AM

This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)

Front Neurosci 13: 1112

We frequently update this page to ensure you have the most current news and information relevant to your claim

Core weight management practices are still recommended as most insurances require demonstration of a concerted effort and some weight loss success before approval for surgery